Yunxiang Mu
Papers
1
Total Citations
421
H-Index
1
About
Yunxiang Mu has made pioneering contributions to immunoproteomics and infectious disease research, with a particular focus on high-throughput platforms for vaccine and diagnostic antigen discovery. Their landmark 2005 study, cited over 420 times, introduced a scalable PCR recombination cloning and expression system that enabled the rapid production of complete proteomes from human pathogens—a critical breakthrough at a time when genome sequences far outpaced functional protein analysis. By coupling this platform with proteome microarrays, Mu’s work allowed researchers to systematically profile humoral immune responses, identifying novel antigens for vaccine development and serodiagnosis. This approach has been instrumental in studying infections caused by complex pathogens, where traditional methods fall short. Mu’s contributions have not only advanced fundamental understanding of host-pathogen interactions but also provided practical tools for global health, streamlining the discovery of targets for diagnostics and vaccines. Their work remains a cornerstone in the field, demonstrating how creative engineering of molecular biology pipelines can unlock new frontiers in immunology and translational medicine.
Research Focus
Key Achievements
Top Papers
- 1